The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 26, 2022

Filed:

Dec. 19, 2018
Applicant:

Ea Pharma Co., Ltd., Chuo-ku, JP;

Inventors:

Daisuke Kataoka, Tokyo, JP;

Kazuo Kuyama, Aichi, JP;

Kenji Asano, Aichi, JP;

Hirotaka Wagatsuma, Kanagawa, JP;

Atsushi Tsuruta, Kanagawa, JP;

Toshiyuki Takanohashi, Kanagawa, JP;

Assignee:

EA Pharma Co., Ltd., Chuo-ku, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61P 5/18 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 9/0019 (2013.01); A61P 5/18 (2018.01);
Abstract

A medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis, said medicinal composition comprising 3-{[(2S)-2-amino-2-carboxyethyl]carmaboylamino}-5-chloro-4-methylbenzenesulfonic acid or a pharmaceutically acceptable salt thereof, or a solvate of the same which is to be administered by a predefined route in a predefined dosage. According to the present invention, it is possible to provide a prophylactic or therapeutic agent for secondary hyperparathyroidism under maintenance dialysis, said agent showing reduced side effects or no significant accumulation. This medicinal agent allows easy administration management and has a high safety compared with conventional products.


Find Patent Forward Citations

Loading…